Involvement of the PI 3-kinase signaling pathway in progression of colon adenocarcinoma

Carcinogenesis

Volumn 25, Issue 2, 2004, Pages 241-248

  Khaleghpour, Kianoush ^a   Li, Yang ^a   Banville, Denis ^a   Yu, Zhenbao ^a   Shen, Shi Hsiang ^a,b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANDROSTANE DERIVATIVE; DNA BINDING PROTEIN; ENZYME INHIBITOR; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN P110; PROTEIN P85; PROTO ONCOGENE PROTEIN AKT; PROTO-ONCOGENE PROTEIN AKT; S6 KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; WORTMANNIN;

ADENOCARCINOMA; CANCER GROWTH; CARCINOGENESIS; CELL CULTURE; CELL GROWTH; CELL LINE; CELL TRANSFORMATION; COLON ADENOCARCINOMA; COLON TUMOR; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; ENZYME INHIBITION; ENZYME SUBUNIT; ENZYMOLOGY; HUMAN; HUMAN CELL; INTESTINE CELL; METABOLISM; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOCARCINOMA; ANDROSTADIENES; COLONIC NEOPLASMS; DISEASE PROGRESSION; DNA-BINDING PROTEINS; ENZYME INHIBITORS; FORKHEAD TRANSCRIPTION FACTORS; GENES, TUMOR SUPPRESSOR; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 1242307944     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg195     Document Type: Review

References (79)

1. Hills,C.S. and Treisman,R. (1995) Transcriptional regulation by extracellular signals: mechanism and specificity. Cell, 80, 199-211.
2. Hunter,T. (2000) Signaling-2000 and beyond. Cell, 100, 113-127.
3. Vivanco,I. and Sawyers,C.L. (2002) The phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nature Rev. Cancer, 2, 489-501.
4. Brunet,A., Bonni,A., Zigmond,M.J. et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell, 96, 857-868.
5. Chang,H.W., Aoki,M., Fruman,D., Auger,K.R., Bellacosa,A., Tsichlis,P.N., Cantley,L.C., Roberts,T.M. and Vogt,P.K. (1997) Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science, 276, 1848-1850.
6. Datta,S.R., Brunet,A. and Greenberg,M.E. (1999) Cellular survival: a play in three Akts. Genes Dev., 13, 2905-2927.
7. Hutchinson,J., Jin,J., Cardiff,R.D., Woodgett,J.R. and Muller,W.J. (2001) Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol. Cell. Biol., 21, 2203-2212.
8. S6K defines its role in protein synthesis and rapamycin sensitivity. Proc. Natl Acad. Sci. USA, 95, 5033-5038.
9. Kennedy,S.G., Wagner,A.J., Conzen,S.D., Jordan,J., Bellacosa,A., Tsichlis,P.N. and Hay,N. (1997) The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11, 701-713.
10. Kulik,G., Klippel,A. and Weber,M.J. (1997) Antiapoptotic signalling by the insulin-like growth factor 1 receptor, phosphoinositol 3-kinase and Akt. Mol. Cell. Biol., 17, 1595-1606.
11. Marte,B.M. and Downward,J. (1997) PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci., 22, 355-358.
12. Rameh,L.E. and Cantley,L.C. (1999) The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem., 274, 8347-8350.
13. s6k gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J., 17, 6649-6659.
14. Shioi,T., Kang,P.M., Douglas,P.S., Hampe,J., Yballe,C.M., Lawitts,J., Cantley,L.C. and Izumo,S. (2000) The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J., 19, 2537-2548.
15. Toker,A. and Cantley,L.C. (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature, 387, 673-676.
16. Verdu,J., Buratovich,M.A., Wilder,E.L. and Birnbaum,M.J. (1999) Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nature Cell Biol., 1, 500-506.
17. Vinals,F., Chambard,J.C. and Pouyssegur,J. (1999) p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation. J. Biol. Chem., 274, 26776-26782.
18. Shayesteh,L., Lu,Y., Kuo,W.-L. et al. (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nature Genet., 21, 99-102.
19. Sasaki,T., Irie-Sasaki,J., Horie,Y. et al. (2000) Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ. Nature, 406, 897-901.
20. Cheng,J.Q., Godwin,A.K., Bellacosa,A., Taguchi,T., Franke,T.F., Hamilton,T.C., Tsichlis,P.N. and Testa,J.R. (1992) Akt2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl Acad. Sci. USA, 89, 9267-9271.
21. kip1 expression. J. Biol. Chem., 275, 24500-24505.
22. Haas-Kogan,D., Shalev,N., Wong,M., Mills,G., Yount,G. and Stokoe,D. (1998) Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr. Biol., 8, 1195-1198.
23. Itoh,N., Semba,S., Ito,M., Takeda,H., Kawata,S. and Yamakawa,M. (2002) Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer, 94, 3127-3134.
24. S6k dependent pathway. Cancer Res., 58, 5239-5247.
25. Page,C., Huang,M., Jing,X., Cho,K., Lilja,J., Reynolds,R.K. and Lin,J. (2000) Elevated phosphorylation of Akt and Stat3 in prostate, breast and cervical cancer cells. Int. J. Oncol., 17, 23-28.
26. Ringel,M.D., Hayre,N., Saito,J. et al. (2001) Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res., 61, 6105-6111.
27. Roy,H.K., Olusola,B.F., Clemens,D.L., Karolski,W.J., Ratashak,A., Lynch,H.T. and Smyrk,T.C. (2002) Akt proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. Carcinogenesis, 23, 201-205.
28. Ruggeri,B.A., Huang,L., Wood,M., Cheng,J.Q. and Testa,J.R. (1998) Amplification and overexpression of the AKT2 oncogene in a subset of human. pancreatic ductal adenocarcinomas. Mol. Carcinog., 2, 81-86.
29. Shao,J., Sheng,H., Inoue,H., Morrow,J.D. and DuBois,R.N. (2000) Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J. Biol. Chem., 275, 33951-33956.
30. Staal,P.S. (1987) Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in primary human gastric adenocarcinoma. Proc. Natl Acad. Sci. USA, 84, 5034-5037.
31. Yuan,Z.Q., Sun,M., Feldman,R.I., Wang,G., Ma,X.-L., Jiang,C., Coppola,D., Nicosia,S.V. and Cheng,J.Q. (2000) Frequent activation of Akt2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene, 19, 2324-2330.
32. S6K pathway in human pancreatic cancer cells. Cancer Res., 59, 3581-3587.
33. Ostrowski,J., Woszczynski,M., Kowaiczyk,P., Wocial,T., Hennig,E., Trzeciak,L., Janik,P. and Bomszytk,K. (2000) Increased activity of MAP, p70 S6 and p90rs kinases is associated with AP-1 activation in spontaneous liver tumors, but not in adjacent tissue in mice. Br. J. Cancer, 82, 1041-1051.
34. S6K signaling is required for pancreatic cancer cell proliferation. J. Surg. Res., 97, 123-130.
35. Franke,T.F., Kaplan,D.R. and Cantley L.C. (1997) PI3K: downstream AKTion blocks apoptosis. Cell, 88, 435-437.
36. Downward,J. (1998) Lipid-regulated kinases: some common themes at last. Science, 279, 673-674.
37. Maehama,T. and Dixon,J.E. (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem., 273, 13375-13378.
38. Myers,M.P., Pass,I., Batty,I.H., Van der Kay,J., Stolarov,J.P., Hemmings,B.A., Wigler,M.H., Downes,C.P. and Tonks,N.K. (1998) The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl Acad. Sci. USA, 95, 13513-13518.
39. Stambolic,V.A., Suzuki,A., de la Pompa,J.L. et al. (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell, 95, 29-39.
40. Cantley,L.C. and Neel,B.G. (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl Acad. Sci. USA, 96, 4240-4245.
41. Franke,T.F., Kaplan,D.R., Cantley,L.C. and Toker,A. (1997) Direct regulation of the Akt proto-oncogene product by the phosphatidylinositol-3,4-bisphosphate. Science, 275, 665-668.
42. Datta,S.R., Dudek,H., Tao,X., Masters,S., Fu,H., Gotoh,Y. and Greenberg,M.E. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231-241.
43. de Peso,L., Gonzalez-Garcia,M., Page,C., Herrera,R. and Nunez,G. (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science, 278, 687-689.
44. Cardone,M.H., Roy,N., Stennicke,H.R., Salvesen,G.S., Franke,T.F., Stanbridge,E., Frisch,S. and Reed,J.C. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science, 282, 1318-1321.
45. Kops,G.J.P.L. and Burgering,B.M. (1999) Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling. J. Mol. Biol., 77, 656-665.
46. Rena,G., Guo,S., Cichy,S.C., Unterman,T.G. and Cohen,P. (1999) Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J. Biol. Chem., 274, 17179-17183.
47. Rena,G., Woods,Y.L., Prescott,A.R., Peggie,M., Unterman,T.G. and Cohen,P. (2002) Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J., 21, 2263-2271.
48. Kops,G.J.P.L., de Ruiter,N.D., De Vries-Smits,A.M.M., Powell,D.R., Bos,J.L. and Burgering,B.M.Th. (1999) Direct control of the forkhead transcription factor AFX by protein kinase B. Nature, 398, 630-634.
49. Nakae,J., Park,B.-C. and Accili,D. (1999) Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway. J. Biol. Chem., 274, 15982-15985.
50. Biggs,W.H.,III, Meisenhelder,J., Hunter,T., Cavenee,W.K. and Arden,K.C. (1999) Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl Acad. Sci. USA, 96, 857-868.
51. Guo,S.D., Rena,G., Cichy,S., He,X.W., Cohen,P. and Unterman,T.G. (1999) Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J. Biol. Chem., 274, 17184-17192.
52. Takaishi,H., Konishi,H., Matsuzaki,H. et al. (1999) Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc. Natl Acad. Sci. USA, 96, 11836-11841.
53. Tang,E.D., Nunez,G., Barr,F.G. and Guan,K.L. (1999) Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem., 274, 16741-16746.
54. Nave,B.T., Ouwens,M., Withers,D.J., Alessi,D.R. and Shepherd,P.R. (1999) Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J., 344, 427-431.
55. Reynolds,T.H., Bodine,S.C. and Lawrence,J.C.,Jr (2002) Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J. Biol. Chem., 277, 17657-17662.
56. Scott,P.H., Brunn,G.J., Kohn,A.D., Roth,R.A. and Lawrence,J.C.,Jr (1998) Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc. Natl Acad. Sci. USA, 95, 7772-7777.
57. Fumagalli,S. and Thomas,G. (2000) S6 phosphorylation and signal transduction. In Sonenberg,N., Hershey,J.W.B. and Mathews,M.B. (eds), Translational Control of Gene Expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
58. Alessi,D.R., Kozlowski,M.T., Weng,Q.P., Morrice,N. and Avruch,J. (1998) 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol., 8, 69-81.
59. Balendran,A., Currie,R., Armstrong,C.G., Avruch,J. and Alessi,D.R. (1999) Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 S6 kinase in vivo at Thr-412 as well as Thr-252. J. Biol. Chem., 274, 37400-37406.
60. Burnett,P.E., Barrow,R.K., Cohen,N.A., Snyder,S.H. and Sabatini,D.M. (1998) RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl Acad. Sci. USA, 95, 1432-1437.
61. Isotani,S., Hara,K., Tokunaga,C., Inoue,H., Avruch,J. and Yonezawa,K. (1999) Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro. J. Biol. Chem., 274, 34493-34498.
62. s6k by PDK1. Science, 279, 707-710.
63. s6k. EMBO J., 16, 3693-3704.
64. Meyuhas,O. and Hornstein,E. (2000) Translational control of TOP mRNAs. In Sonenberg,N., Hershey,J.W.B. and Mathews,M.B. (eds), Translational Control of Gene Expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
65. Thomas,G. and Hall,M.N. (1997) TOR signalling and control of cell growth. Curr. Opin. Cell Biol., 9, 782-787.
66. Trainer,D.L., Kline,T., McCabe,F.L. et al. (1988) Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int. J. Cancer, 41, 287-296.
67. Alessi,D.R., Andjelkovic,M., Caudwell,B., Cron,P., Morrice,N., Cohen,P. and Hemmings,B.A. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J., 15, 6541-6551.
68. Stokoe,D., Stephens,L.R., Copeland,T., Gaffney,P.R., Reese,C.B., Painter,G.F., Holmes,A.B., McCormick,F. and Hawkins,P.T. (1997) Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science, 277, 567-570.
69. de Peso,L., Gonzalez,V.M., Hernandez,R., Barr,F.G. and Nunez,G. (1999) Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, but the serine/threonine kinase Akt. Oncogene, 18, 7328-7333.
70. Zheng,W.-H., Kar,S. and Quirion,R. (2000) Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. J. Biol. Chem., 275, 39152-39158.
71. kip1. Nature, 404, 782-786.
72. Brownawell,A.M., Kops,G.J., Macara,I.G. and Burgering,B.M. (2001) Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol. Cell. Biol., 21, 3534-3546.
73. Rena,G., Prescott,A.R., Guo,S.D., Cohen,P. and Unterman,T.G. (2001) Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targeting. Biochem. J., 354, 605-612.
74. Datta,K., Bellacosa,A., Chan,T.O. and Tsichlis,P.N. (1996) Akt is a direct target of the phosphoinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells. J. Biol. Chem., 271, 30835-30839.
75. Taniyama,K., Goodison,S., Ito,R., Bookstein,R., Miyoshi,N., Tahara,E., Tarin,D. and Urquidi,V. (2001) PTEN expression is maintained in sporadic colorectal tumours. J. Pathol., 194, 341-348.
76. Ballou,L.M., Siegmann,M. and Thomas,G. (1988) S6 kinase in quiescent Swiss mouse 3T3 cells is activated by phosphorylation in response to serum treatment. Proc. Natl Acad. Sci. USA, 85, 7154-7158.
77. Proud,C.G. (1996) p70 S6 kinase: an enigma with variations. Trends Biochem. Sci., 21, 181-185.
78. s6k. FEBS Lett., 410, 78-82.
79. Pearson,R.B., Dennis,P.B., Han,J.W., Williamson,N.A., Kozma,S.C., Wettenhall, R.E. and Thomas,G. (1995) The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J., 14, 5279-5287.